Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Récupération après la fatigue chez les jeunes athlètes : comparaison entre la thérapie TECAR et l'ergomètre à vélo

Effets immédiats et à court terme de la thérapie TECAR et du cycloergomètre sur la récupération après fatigue chez les jeunes athlètes : un essai contrôlé randomisé

The goal of this clinical trial is to compare two recovery methods after fatigue in young athletes. It aims to find out if tecar therapy (TECAR) or cycle ergometer exercise can improve recovery after intense physical activity and help athletes return to their normal performance more quickly.

The main questions it aims to answer are:

Does TECAR or cycle ergometer improve physical performance after fatigue?

Do these methods reduce muscle pain and soreness after fatigue?

Researchers will compare TECAR with active recovery using a cycle ergometer to see which method is more effective.

Participants will:

Perform a series of jumps to induce fatigue

Be randomly assigned to one of the recovery methods

Complete physical tests before and after fatigue

Undergo simple measurements of muscle condition and pain

Report their level of effort and muscle soreness

Aperçu de l'étude

Description détaillée

This study is a randomized controlled trial designed to evaluate and compare the effectiveness of two recovery strategies following exercise-induced fatigue in young athletes: tecar therapy (TECAR) and active recovery (usual care) using a cycle ergometer.

Exercise-induced fatigue can reduce physical performance and increase muscle soreness, which may negatively affect athletic performance and increase injury risk. This study aims to compare the effects of two commonly used recovery strategies on physical performance, muscle mechanical properties, and perceived recovery.

Participants will be physically active young athletes over 18 years of age, familiar with plyometric or jump-based activities. They will be recruited through convenience sampling. Individuals with recent musculoskeletal injuries or those who have performed intense physical exercise within 24 hours prior to testing will be excluded.

All procedures will be conducted in a controlled environment by trained personnel following a standardized protocol. After providing informed consent, participants will undergo baseline assessments, including physical performance tests, measurements of muscle mechanical properties, and subjective perception of effort and muscle soreness.

A standardized warm-up will be performed prior to testing, consisting of low-intensity aerobic activity for approximately five minutes, aiming to reach a moderate level of perceived exertion.

Participants will then complete a fatigue protocol consisting of repeated drop jumps from a fixed height of approximately 0.6 meters. The protocol will be organized into multiple sets with controlled rest intervals between repetitions and sets in order to induce acute neuromuscular fatigue in a standardized manner.

Immediately after the fatigue protocol, the same assessments will be repeated to evaluate the acute effects of fatigue.

Participants will then be randomly assigned to one of the two recovery interventions:

TECAR: application of capacitive and resistive electric transfer using radiofrequency energy for 20 minutes

Active recovery (usual care): continuous cycling on a cycle ergometer at low-to-moderate intensity for 20 minutes, reflecting standard recovery practices commonly used in athletic settings

Following the assigned recovery intervention, all assessments will be repeated to evaluate recovery effects.

In addition, subjective measures of muscle soreness and perceived effort will be collected at 12 and 24 hours after the intervention to assess short-term recovery.

Outcome measures will include objective indicators of physical performance and muscle mechanical properties, assessed using a handheld myotonometer, as well as pressure pain threshold (a measure of sensitivity to pressure), and subjective measures related to perceived effort and muscle soreness.

Statistical analysis will include descriptive statistics and inferential analysis to compare differences between groups and over time. A two-way analysis of variance (group × time) will be used to evaluate the effects of the recovery intervention and measurement time points, including potential interaction effects. Statistical significance will be set at p < 0.05.

This study aims to provide evidence on the comparative effectiveness of TECAR and active recovery strategies, contributing to the optimization of recovery protocols in athletic populations.

Type d'étude

Interventionnel

Inscription (Estimé)

48

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

  • Nom: Sandra Alcaraz Clariana, PhD PT
  • Numéro de téléphone: +34625434043
  • E-mail: m72alcls@uco.es

Sauvegarde des contacts de l'étude

  • Nom: Lourdes García Luque, PhD PT
  • Numéro de téléphone: +34627366324
  • E-mail: z12galul@uco.es

Lieux d'étude

    • Córdoba
      • Córdoba, Córdoba, Espagne, 14011
        • Recrutement
        • Physiobalance
        • Contact:
          • Sandra Alcaraz Clariana, PhD PT
          • Numéro de téléphone: +34625434043
          • E-mail: m72alcls@uco.es
        • Contact:
          • Lourdes García Luque, PhD PT
          • Numéro de téléphone: +34627366324
          • E-mail: z12galul@uco.es
        • Chercheur principal:
          • Sandra Alcaraz Clariana, PhD PT
        • Sous-enquêteur:
          • Lourdes García Luque, PhD PT

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Adults aged 18 years or older
  • Engaging in regular physical activity
  • Experience with sports involving jumping or plyometric exercises

Exclusion Criteria:

  • Performed intense physical exercise within 24 hours before the study
  • Planned to perform intense physical exercise within 24 hours after the study
  • Presence of muscle soreness at the beginning of the study
  • Musculoskeletal injury in the previous 6 months

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Double

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: TECAR

Participants assigned to this group will receive tecar therapy (TECAR) for 20 minutes. TECAR will be applied using the capacitive mode only, combining manual mobile application and fixed automatic application. The intervention will be applied after a standardized fatigue protocol consisting of repeated drop jumps, which is identical for all participants.

TECAR is applied using capacitive radiofrequency energy for 20 minutes following a standardized fatigue protocol. The intervention is delivered using capacitive mode only, combining manual mobile application and fixed automatic application over the quadriceps region to promote recovery after exercise-induced fatigue.

Autres noms:
  • Thérapie par transfert électrique capacitif et résistif. Thérapie par radiofréquence
Comparateur actif: Active recovery (usual care)

Participants assigned to this group will perform active recovery (usual care) consisting of continuous cycling on a cycle ergometer for 20 minutes at low intensity, not exceeding 2-3 on a 0-10 rating of perceived exertion scale. The intervention will be applied after a standardized fatigue protocol consisting of repeated drop jumps, which is identical for all participants. This intervention reflects standard recovery practices commonly used in athletic settings.

Active recovery consists of continuous cycling on a cycle ergometer for 20 minutes at low intensity, not exceeding 2-3 on a 0-10 rating of perceived exertion scale. This intervention is performed after a standardized fatigue protocol and reflects common recovery practices in athletic settings.

Autres noms:
  • Exercice cycliste de faible intensité

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Countermovement jump height
Délai: Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).

Vertical jump performance will be assessed using a countermovement jump test. Jump height will be measured using a validated mobile application after three attempts, and the mean value will be recorded.

Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Muscle mechanical properties
Délai: Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).

Muscle mechanical properties will be assessed using a handheld myotonometer. Parameters will include muscle tone and stiffness measured at standardized anatomical locations of the rectus femoris, vastus lateralis, medial gastrocnemius, and lateral gastrocnemius.

Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).
Pressure pain threshold
Délai: Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).

Pressure pain threshold will be assessed using a handheld algometer. Measurements will be performed at standardized anatomical locations of the rectus femoris, vastus lateralis, and medial gastrocnemius, and the mean of repeated measurements will be recorded.

Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).
Rating of perceived exertion
Délai: Baseline (after warm-up), immediately after fatigue protocol, immediately after intervention (20 minutes), 12 hours, and 24 hours.

Perceived exertion will be assessed using a 0-10 rating scale, where higher values indicate greater perceived effort.

Baseline (after warm-up), immediately after fatigue protocol, immediately after intervention (20 minutes), 12 hours, and 24 hours.
Delayed-onset muscle soreness.
Délai: Baseline (after warm-up), 12 hours, and 24 hours.

Delayed-onset muscle soreness (DOMS) will be assessed using a 0-10 numeric rating scale, where 0 indicates no muscle soreness and 10 indicates the worst possible muscle soreness.

Baseline (after warm-up), 12 hours, and 24 hours.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Sandra Alcaraz Clariana, PhD PT, Maimonides Biomedical Research Institute of Cordoba (IMIBIC). Department of Nursing, Pharmacology and Physical Therapy, Faculty of Medicine and Nursing, University of Córdoba, Córdoba, Spain;

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

27 avril 2026

Achèvement primaire (Estimé)

1 décembre 2026

Achèvement de l'étude (Estimé)

1 février 2027

Dates d'inscription aux études

Première soumission

26 mars 2026

Première soumission répondant aux critères de contrôle qualité

16 avril 2026

Première publication (Réel)

23 avril 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

5 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

3 novembre 2026

Dernière vérification

1 mars 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner